Antifungal prophylaxis in lung transplantation

Area of Science:

• Medicine
• Infectious Diseases
• Transplantation

Background:

• Fungal infections are a significant complication following lung transplantation, occurring in 6-10% of recipients within the first year.
• These infections are more prevalent in lung transplant recipients compared to other solid organ transplant recipients.
• A variety of fungi, including Aspergillus spp., Candida spp., Cryptococcus, Pneumocystis, and endemic mycoses, can cause active infections.

Purpose of the Study:

• To review the primary fungal organisms implicated in lung transplant recipients.
• To discuss the diverse clinical presentations of fungal infections in this population.
• To explore current and varied strategies for antifungal prophylaxis and prevention.

Main Methods:

• This is a review article, synthesizing existing literature on fungal infections in lung transplantation.
• It analyzes the epidemiology, clinical manifestations, and management of fungal infections.
• Focuses on prevention strategies, including antifungal prophylaxis.

Main Results:

• Aspergillus species are the most frequent cause of invasive fungal infections post-lung transplant.
• Clinical presentations are varied, encompassing pulmonary disease, airway infections, empyemas, and disseminated disease.
• Antifungal prophylaxis protocols differ significantly across transplant centers regarding agents, dosages, duration, and monitoring.

Conclusions:

• Fungal infections pose a serious threat to lung transplant recipients, necessitating careful monitoring and management.
• Standardization of antifungal prophylaxis strategies is needed due to current center-specific variations.
• Effective prevention and early recognition are crucial for improving outcomes in lung transplant recipients.